Eli Lilly and Company (NYSE: LLY) today announced detailed results from the QWINT-5 phase 3 trial evaluating once-weekly ...
New research published in New England Journal of Medicine and presented at this year's Annual Meeting of the European ...
The Brighterside of News on MSN7d
Once-weekly insulin as effective as daily injections for patients with type 2 diabetesA new study highlights promising results for a once-weekly insulin injection in managing blood sugar levels for people with ...
People with type 1 or type 2 diabetes could soon benefit from weekly insulin injections after new research showed they are as effective at controlling blood sugar levels as daily jabs of long-acting ...
The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for ...
New research published in NEJM and presented at this year's Annual Meeting of the European Association for the Study of ...
Clinical trials of a new, once-a-week insulin have shown that it controls blood sugar as well as daily injections of an ...
Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...
The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...
Implanting a pouch of stem-cell-derived pancreas cells under the skin of type 1 diabetics has enabled them to live without ...
For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...
New research published in NEJM and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9-13 Sept) shows that a new class of insulin that is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback